{"id":"6df46071-7790-5fb3-8242-9a1e0b425c36","stable_key":"d2e91bc7-8177-5ad3-ad9b-5d65813ce082:naringenin-conjugate-albumin","predicate":"forms_more_stable_complexes_with","statement":"Naringenin sulfate conjugates formed more stable complexes with human serum albumin than the parent flavonoid in vitro.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"78432a31-154f-5aa8-b59c-879adfe71df6","mechanism_event_label":"Naringenin sulfate conjugates formed more stable complexes with human serum albumin than the parent flavonoid in vitro.","subject":{"id":"8d3fb1b0-bcda-52f6-9999-0259e2e56630","slug":"naringenin-sulfate-pool","display_name":"Naringenin sulfate conjugates","entity_type_key":"small_molecule"},"object":{"id":"d74adc7c-c253-5604-99bf-73d5ed0c0701","slug":"human-serum-albumin","display_name":"Human serum albumin","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"78432a31-154f-5aa8-b59c-879adfe71df6","stable_key":"d2e91bc7-8177-5ad3-ad9b-5d65813ce082:naringenin-conjugate-albumin-event","event_type":"observed_relationship","label":"Naringenin sulfate conjugates formed more stable complexes with human serum albumin than the parent flavonoid in vitro.","description":"Naringenin sulfate conjugates formed more stable complexes with human serum albumin than the parent flavonoid in vitro.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8d3fb1b0-bcda-52f6-9999-0259e2e56630","slug":"naringenin-sulfate-pool","display_name":"Naringenin sulfate conjugates","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"d74adc7c-c253-5604-99bf-73d5ed0c0701","slug":"human-serum-albumin","display_name":"Human serum albumin","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"2a9350f6-01cc-5bea-8213-cd3ebb1b05cf","slug":"naringenin","display_name":"Naringenin","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"dose","value_text":"Naringenin and sulfate/glucuronide conjugates","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"Equilibrium assay","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_scope","value_text":"literature_reviewed; model-specific source-derived curation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Cell-free human serum albumin binding assays","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Binding does not establish tissue delivery or a clinically important displacement interaction.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Naringenin chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings.","comparator":null,"unit":null,"notes":"","entity":{"slug":"naringenin","display_name":"Naringenin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Cell-free human serum albumin binding assays","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Naringenin sulfate conjugates formed more stable complexes with human serum albumin than the parent flavonoid in vitro.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. (2023). https://pubmed.ncbi.nlm.nih.gov/36481402/ DOI: 10.1016/j.biopha.2022.114078","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vitro","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Ligand-protein binding","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"aa4ff56f-d6d4-523e-ab6c-f4b62db79756","evidence_kind":"source_excerpt","locator":"Lines 66-75","start_line":66,"end_line":75,"excerpt":"## naringenin-conjugate-albumin\nNaringenin sulfate conjugates formed more stable complexes with human serum albumin than the parent flavonoid in vitro.\nModel/species: Cell-free human serum albumin binding assays\nTissue/system: Ligand-protein binding\nExposure: Naringenin and sulfate/glucuronide conjugates\nRoute: In vitro\nDuration: Equilibrium assay\nLimits: Binding does not establish tissue delivery or a clinically important displacement interaction.\nPrimary reference: Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. (2023). https://pubmed.ncbi.nlm.nih.gov/36481402/ DOI: 10.1016/j.biopha.2022.114078\nAccess: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","model_system":"Cell-free human serum albumin binding assays","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Exact original curation span with primary citation; not a publisher quotation.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"2804932d-46eb-5c43-8a45-0505e6b1ee05","stable_key":"import-d2e91bc7-8177-5ad3-ad9b-5d65813ce082","title":"Naringenin: mechanism of action and interactions (2026-09-20)","document_type":"imported_text","citation_label":"Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text.","file_path":"","sha256":"e74776bf312a9ab53a4510c483e36e3093829e8c38725b9ae061e59e86f1145a","revision_id":"b96b5487-2b33-56ff-8955-9e8c0833533b","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}